Tarsus Pharmaceuticals (TARS) Insider Trading & Ownership → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free TARS Stock Alerts $37.00 +2.96 (+8.70%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.54%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$178,660.80Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$5.28 M Get TARS Insider Trade Alerts Want to know when executives and insiders are buying or selling Tarsus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TARS Insider Buying and Selling by Quarter Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here Tarsus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/18/2024Aziz MottiwalaInsiderSell4,766$30.60$145,839.60 3/18/2024Bobak R AzamianCEOSell10,415$30.60$318,699.00 3/18/2024Bryan WahlGeneral CounselSell4,436$30.60$135,741.60 3/18/2024Seshadri NeervannanCOOSell4,879$30.60$149,297.40 12/27/2023Bobak R AzamianCEOSell8,000$20.22$161,760.00 12/20/2023Bobak R AzamianCEOSell40,000$20.27$810,800.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/20/2023Jose M TrevejoInsiderSell2,252$20.00$45,040.00 12/15/2023Andrew D GoldbergDirectorBuy1,000$18.96$18,960.00 11/30/2023Bryan WahlGeneral CounselSell8,356$16.31$136,286.36 11/30/2023Dianne C WhitfieldInsiderSell8,355$16.31$136,270.05 10/18/2023Bobak R AzamianCEOSell8,000$13.24$105,920.00 10/5/2023Jose M TrevejoInsiderSell1,604$18.00$28,872.00 9/20/2023Bobak R AzamianCEOSell8,000$17.21$137,680.00 8/23/2023Bobak R AzamianCEOSell8,000$17.23$137,840.00 8/15/2023Elizabeth Yeu LinDirectorBuy9,506$16.80$159,700.80 7/19/2023Aziz MottiwalaInsiderSell2,400$20.05$48,120.00 7/19/2023Bobak R AzamianCEOSell103,900$20.01$2,079,039.00 7/12/2023Bobak R AzamianCEOSell9,000$17.35$156,150.00 6/21/2023Bobak R AzamianCEOSell8,000$18.63$149,040.00 6/14/2023Bobak R AzamianCEOSell9,000$18.58$167,220.00 6/8/2023Aziz MottiwalaInsiderSell100$20.00$2,000.00 6/8/2023Bobak R AzamianCEOSell3,100$20.01$62,031.00 6/6/2023Aziz MottiwalaInsiderSell2,143$18.61$39,881.23 5/17/2023Bobak R AzamianCEOSell8,000$15.90$127,200.00 (Data available from 1/1/2013 forward) TARS Insider Trading Activity - Frequently Asked Questions Who is on Tarsus Pharmaceuticals's Insider Roster? The list of insiders at Tarsus Pharmaceuticals includes Andrew D Goldberg, Aziz Mottiwala, Bobak R Azamian, Bryan Wahl, Dianne C Whitfield, Elizabeth Yeu Lin, Jose M Trevejo, Leonard M Greenstein, Mark J Holdbrook, Michael Ackermann, Seshadri Neervannan, and Vivo Capital Ix, Llc. Learn more on insiders at TARS. What percentage of Tarsus Pharmaceuticals stock is owned by insiders? 11.54% of Tarsus Pharmaceuticals stock is owned by insiders. Learn more on TARS's insider holdings. Which Tarsus Pharmaceuticals insiders have been buying company stock? The following insiders have purchased TARS shares in the last 24 months: Andrew D Goldberg ($18,960.00), and Elizabeth Yeu Lin ($456,308.80). How much insider buying is happening at Tarsus Pharmaceuticals? Insiders have purchased a total of 28,906 TARS shares in the last 24 months for a total of $475,268.80 bought. Which Tarsus Pharmaceuticals insiders have been selling company stock? The following insiders have sold TARS shares in the last 24 months: Aziz Mottiwala ($357,346.87), Bobak R Azamian ($6,387,921.94), Bryan Wahl ($305,087.62), Dianne C Whitfield ($179,479.24), Jose M Trevejo ($87,281.86), Leonard M Greenstein ($537,152.33), Mark J Holdbrook ($5,008.19), and Seshadri Neervannan ($163,674.27). How much insider selling is happening at Tarsus Pharmaceuticals? Insiders have sold a total of 441,607 Tarsus Pharmaceuticals shares in the last 24 months for a total of $8,022,952.32 sold. More Insider Trading Tools from MarketBeat Related Companies: Scholar Rock Insider Trades Cullinan Oncology Insider Trades 4D Molecular Therapeutics Insider Trades Relay Therapeutics Insider Trades BioCryst Pharmaceuticals Insider Trades REGENXBIO Insider Trades CARGO Therapeutics Insider Trades Neumora Therapeutics Insider Trades ADMA Biologics Insider Trades HilleVax Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:TARS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.